Blockbuster Cancer Drug Can Now Be Administered More Easily

(Medage today) – The FDA has approved a subcutaneous formulation of the PEMBROLIZUMAB (KEYTRUDA QLEX) blockbuster drug drug drugs for use through the many solid drug tumors. The new formulation combines pembrolizumab with berahyaluronidase …